An optimal tumor antigen needs to be i) distinct from the self-endogenous peptides, ii) processed correctly and intracellularly, iii) loaded onto MHC molecules efficiently, and iv) have the structural properties to mediate a sufficiently long interaction between T cells and the antigen-presenting cell. This evidence concerns the gene HLA-C and neoplasm.